ENDOSCOPIC SLEEVE GASTROPLASTY FOR OBESITY TREATMENT: TWO YEARS OF EXPERIENCE
Gontrand Lopez-Nava, M P Galvão, I Bautista-Castaño, J P Fernandez-Corbelle, M Trell, N Lopez, Gontrand Lopez-Nava, M P Galvão, I Bautista-Castaño, J P Fernandez-Corbelle, M Trell, N Lopez
Abstract
Background: Bariatric endoscopic techniques are minimally invasive and induce gastric volume reduction to treat obesity. Aim : To evaluate endoscopic sleeve gastroplasty (Apollo method) using a suturing method directed at the greater curvature, as well as the perioperative care, two year safety and weight loss.
Method: Prospective single-center study over 154 patients (108 females) using the endoscopic sleeve gastroplasty procedure under general anesthesia with overnight inpatient observation. Of the154 initial patients, 143 were available for 1-month of follow-up, 133 for 6-month, 64 for 12-month and 28 completed the 24 month assessment. Follow-up was carried out by a multidisciplinary team (nutritionist and psychologist). Outcomes evaluated were: change in BMI; change in body weight (TBWL); % of loss of initial body weight (%TBWL); % of excess body weight loss (%EWL) (segregated in > or <25% and adverse effects. Voluntary oral contrasted radiological examinations were scheduled to assess the gastroplasty at different times post-procedure.
Results: Mean age was 44.9 (23-69) years. At 24 months after the procedure baseline mean BMI change from 38.3 to 30.8 kg/m2. TBWL, %TBWL and %EWL were of 21.3 kg, 19.5% and 60.4% respectively. 85.7% of patients achieve the goal of >25% %EWL. There were no mayor adverse events intraprocedure or during the 24 months of follow-up .
Conclusion: Endoscopic sleeve gastroplasty with regular monitoring by a multidisciplinary team can be considered an effective, safe and well tolerated procedure for obesity treatment, at least for two years of follow-up.
Conflict of interest statement
Conflito de interesse: The GLN and MG authors are consultants to the Apollo Endosurgery Company and have received financial support for teaching programs. The other authors declare that they have no conflict of interest.
Figures
References
- ASGE Bariatric Endoscopy Task Force. ASGE Technology Committee Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S. Endoscopic bariatric therapies. Gastrointest Endosc. 2015;81:1073–1086.
- ASGE/ASMBS Task Force on Endoscopic Bariatric Therapy Ginsberg GG, Chand B. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011;74:943–953.
- Chang SH, Stoll CR, Song J. The effectiveness and risks of bariatric surgery An updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149:275–287.
- Espinet-Coll E, Nebreda-Durán J, Gómez-Valero JA. Current endoscopic techniques in the treatment of obesity. Rev Esp Enferm Dig. 2012;104:72–87.
- Galvão-Neto MD, Grecco E, Souza TF, Quadros LG, Silva LB, Campos JM. Endoscopic sleeve gastroplasty - minimally invasive therapy for primary obesity treatment. Arq Bras Cir Dig. 2016;29(1) 1:95–97. doi: 10.1590/0102-6720201600S10023.
- López-Nava G, Bautista-Castaño I, Jiménez A. Endoscopic sleeve gastroplasty How I do it. Obes Surg. 2015;25:1534–1538. doi: 10.1007/s11695-015-1714-7.
- Lopez-Nava G, Galvao M, Bautista-Castaño I, Fernandez-Corbelle JP, Trell M. Endoscopic sleeve gastroplasty with 1-year follow-up factors predictive of success. Endosc Int Open. 2016;4(2):E222–E227.
- López-Nava G, Galvão MP, Bautista-Castaño I. Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy. 2015;47(5):449–452.
- Middleton KM, Patidar SM, Perri MG. The impact of extended care on the long-term maintenance of weight loss a systematic review and meta-analysis. Obes Rev. 2012;13(6):509–517.
Source: PubMed